ASC30
AURORA-2
Ascletis Pharma (China) Co · Phase 3 · Recruiting · Enrollment 1560
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
ASC30
Ascletis Pharma (China) Co · Phase 3 · Recruiting · Enrollment 1560
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.